Palbociclib FDA approval date

The FDA approved Palbociclib (IBRANCE) on 3 Feb 2015.

FDA approval date
3 Feb 2015

Drug identity checked against registry records

Also recorded as IBRANCE; PD-0332991

Included trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2015-02-03DayPalbociclibFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA207103", "applicant_as_listed_by_fda": "PFIZER", "brand_names": ["IBRANCE"], "active_ingredients": ["PALBOCICLIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20150203", "matched_on": "drug name equals FDA sole active ingredient"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026